269 related articles for article (PubMed ID: 19734242)
1. Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy.
Olsson DS; Buchfelder M; Schlaffer S; Bengtsson BA; Jakobsson KE; Johannsson G; Nilsson AG
Eur J Endocrinol; 2009 Nov; 161(5):663-9. PubMed ID: 19734242
[TBL] [Abstract][Full Text] [Related]
2. Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up.
Olsson DS; Buchfelder M; Wiendieck K; Kremenevskaja N; Bengtsson BÅ; Jakobsson KE; Jarfelt M; Johannsson G; Nilsson AG
Eur J Endocrinol; 2012 Jun; 166(6):1061-8. PubMed ID: 22457235
[TBL] [Abstract][Full Text] [Related]
3. Life expectancy in patients with pituitary adenoma receiving growth hormone replacement.
Olsson DS; Trimpou P; Hallén T; Bryngelsson IL; Andersson E; Skoglund T; Bengtsson BÅ; Johannsson G; Nilsson AG
Eur J Endocrinol; 2017 Jan; 176(1):67-75. PubMed ID: 27770012
[TBL] [Abstract][Full Text] [Related]
4. Tumor Recurrence or Regrowth in Adults With Nonfunctioning Pituitary Adenomas Using GH Replacement Therapy.
van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
J Clin Endocrinol Metab; 2015 Aug; 100(8):3132-9. PubMed ID: 26057181
[TBL] [Abstract][Full Text] [Related]
5. Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement.
Hammarstrand C; Ragnarsson O; Bengtsson O; Bryngelsson IL; Johannsson G; Olsson DS
Eur J Endocrinol; 2018 Oct; 179(4):229-237. PubMed ID: 30299891
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety of growth hormone replacement after CNS irradiation.
Mackenzie S; Craven T; Gattamaneni HR; Swindell R; Shalet SM; Brabant G
J Clin Endocrinol Metab; 2011 Sep; 96(9):2756-61. PubMed ID: 21715535
[TBL] [Abstract][Full Text] [Related]
7. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency.
Matsumoto R; Fukuoka H; Iguchi G; Nishizawa H; Bando H; Suda K; Takahashi M; Takahashi Y
Growth Horm IGF Res; 2014 Oct; 24(5):174-9. PubMed ID: 25116471
[TBL] [Abstract][Full Text] [Related]
9. Influence of GH substitution therapy in deficient adults on the recurrence rate of hormonally inactive pituitary adenomas: a case control study.
Buchfelder M; Kann PH; Wüster C; Tuschy U; Saller B; Brabant G; Kleindienst A; Nomikos P;
Eur J Endocrinol; 2007 Aug; 157(2):149-56. PubMed ID: 17656592
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.
Frajese G; Drake WM; Loureiro RA; Evanson J; Coyte D; Wood DF; Grossman AB; Besser GM; Monson JP
J Clin Endocrinol Metab; 2001 Nov; 86(11):5172-5. PubMed ID: 11701673
[TBL] [Abstract][Full Text] [Related]
11. Improvements in Body Composition after 4 Years of Growth Hormone Treatment in Adult-Onset Hypopituitarism Compared to Age-Matched Controls.
Postma MR; van Beek AP; Jönsson PJ; van Bunderen CC; Drent ML; Mattsson AF; Camacho-Hubner C
Neuroendocrinology; 2019; 109(2):131-140. PubMed ID: 30844796
[TBL] [Abstract][Full Text] [Related]
12. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas.
Minniti G; Traish D; Ashley S; Gonsalves A; Brada M
Clin Endocrinol (Oxf); 2006 May; 64(5):542-8. PubMed ID: 16649974
[TBL] [Abstract][Full Text] [Related]
13. Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours?
Hatrick AG; Boghalo P; Bingham JB; Ayres AB; Sonksen PH; Russell-Jones DL
Eur J Endocrinol; 2002 Jun; 146(6):807-11. PubMed ID: 12039701
[TBL] [Abstract][Full Text] [Related]
14. Progression of pituitary tumours: impact of GH secretory status and long-term GH replacement therapy.
Gasco V; Caputo M; Cambria V; Beccuti G; Caprino MP; Ghigo E; Maccario M; Grottoli S
Endocrine; 2019 Feb; 63(2):341-347. PubMed ID: 30341707
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone therapy and risk of recurrence/progression in intracranial tumors: a meta-analysis.
Shen L; Sun CM; Li XT; Liu CJ; Zhou YX
Neurol Sci; 2015 Oct; 36(10):1859-67. PubMed ID: 26048536
[TBL] [Abstract][Full Text] [Related]
16. Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence.
Losa M; Castellino L; Pagnano A; Rossini A; Mortini P; Lanzi R
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112101
[TBL] [Abstract][Full Text] [Related]
17. Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
Chung TT; Drake WM; Evanson J; Walker D; Plowman PN; Chew SL; Grossman AB; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2005 Sep; 63(3):274-9. PubMed ID: 16117814
[TBL] [Abstract][Full Text] [Related]
18. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
[TBL] [Abstract][Full Text] [Related]
19. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
Verhelst J; Kendall-Taylor P; Erfurth EM; Price DA; Geffner M; Koltowska-Häggström M; Jönsson PJ; Wilton P; Abs R
J Clin Endocrinol Metab; 2005 Aug; 90(8):4636-43. PubMed ID: 15928246
[TBL] [Abstract][Full Text] [Related]
20. The effect of growth hormone on pituitary tumour growth.
Herring R; Russell-Jones D
Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):365-8. PubMed ID: 20498595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
